2025
How I treat challenging transfusion cases in sickle cell disease
Chou S, Hendrickson J. How I treat challenging transfusion cases in sickle cell disease. Blood 2025, 145: 2257-2265. PMID: 38728382, DOI: 10.1182/blood.2023023648.Peer-Reviewed Original ResearchDelayed Hemolytic Transfusion ReactionSickle cell diseaseRed blood cellsTransfusion of red blood cellsRed blood cell alloantibodiesRed blood cell transfusionCell diseaseHemolytic transfusion reactionsManagement of complicationsAlloimmunized patientsRh alloimmunizationCurative therapyTransfusion guidelinesTransfusion recipientsClinical dilemmaFuture transfusionsTransfusionPatient populationTransfusion casesTransfusion reactionsBlood donorsRH variantsBlood cellsAlloimmunizationMedicine providers
2021
Transfusion practices in a large cohort of hospitalized children
Nellis ME, Goel R, Hendrickson JE, Birch R, Patel RM, Karafin MS, Hanson SJ, Sachais BS, Hauser RG, Luban NLC, Gottschall J, Sola‐Visner M, Josephson CD, Karam O, Study‐IV‐Pediatric F. Transfusion practices in a large cohort of hospitalized children. Transfusion 2021, 61: 2042-2053. PMID: 33973660, DOI: 10.1111/trf.16443.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentBlood Component TransfusionBlood TransfusionChildChild, PreschoolDatasets as TopicDiagnosis-Related GroupsFemaleHospital MortalityHospitals, CommunityHospitals, TeachingHumansInfantInfant, NewbornInpatientsMaleProcedures and Techniques UtilizationRetrospective StudiesUnited StatesConceptsRBC transfusionCardiopulmonary bypassTransfusion practiceHospitalized childrenInpatient encountersBlood componentsLarge cohortHospital settingBlood Institute Recipient EpidemiologyDonor Evaluation Study-IIIPatient blood management initiativesDiagnostic categoriesFrequency of transfusionInstitutional transfusion guidelinesCohort of patientsInternational normalized ratioPercent of encountersNational Heart LungPediatric hospital settingYears of ageSubset of childrenRecipient EpidemiologyTransfusion guidelinesRed blood cellsEntire cohort
2010
Evidence‐based practice guidelines for plasma transfusion
Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B. Evidence‐based practice guidelines for plasma transfusion. Transfusion 2010, 50: 1227-1239. PMID: 20345562, DOI: 10.1111/j.1537-2995.2010.02632.x.Peer-Reviewed Original ResearchConceptsTransfusion of plasmaPlasma transfusionCommon clinical scenariosMassive transfusionEvidence-based guidanceSystematic reviewIntracranial hemorrhageTransfusion decisionsPractice guidelinesClinical scenariosRed blood cell ratioEvidence-based practice guidelinesMultidisciplinary guideline panelPlasma transfusion guidelinesBlood cell ratioGroup of patientsClinical practice guidelinesAppropriate transfusionTransfusion guidelinesWarfarin anticoagulationGRADE methodologyGuideline panelObservational studyTransfusionDefinitive guidelines
1999
Optimal dosing and triggers for prophylactic use of platelet transfusions
Rinder H, Arbini A, Snyder E. Optimal dosing and triggers for prophylactic use of platelet transfusions. Current Opinion In Hematology 1999, 6: 437. PMID: 10546800, DOI: 10.1097/00062752-199911000-00015.Peer-Reviewed Original ResearchConceptsProphylactic platelet transfusionsPlatelet transfusionsPlatelet transfusion guidelinesPlatelet transfusion practicesPlatelet transfusion supportAdequate platelet inventoryTransfusion intervalTransfusion guidelinesTransfusion supportMyeloablative therapyOptimal dosingTransfusion practiceProphylactic useThrombocytopenic patientsOutpatient supportPatient outcomesInpatient settingPlatelet dosePlatelet dosesTransfusionSmall dosesPlatelet inventoryPatientsDosesRecent studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply